Vaccines

The Spanish company CZ Vaccines and Irish firm Marrinovak Ltd have today launched the new aquaculture-focused pharmaceutical venture Aquatreck Animal Health.

Hopes for the development of an effective vaccine to protect tilapia from Streptococcus have been given a boost following the publication of the results of a new study.

New vaccination techniques developed by Mississippi State University (MSU) should help the state’s catfish industry save $40 million a year.

The Ghanaian government has announced plans to be more vigilant against imported tilapia, which are taking the blame for a spate of mortalities that has wiped out up to 80 per cent of the stocks at so…

The Norwegian salmon sector purchased 34.9 million doses of salmon vaccines in November – up from 33.0 million in the same month last year.

Fish farmers in Ghana are calling for government action to stem significant fish mortalities in Lake Volta – home to 90 per cent of the country’s aquaculture production.

Osmo Systems, a Silicon Valley-based startup that makes a new type of water quality sensor for the aquaculture industry, won the Innovation Award at the GOAL conference in Ecuador this week.

Results of a trial that reduced the impact of a new vaccine that proved efficacious against Listonella anguillarum in sea bass were presented at Aqua2018 by Hipra.

The Center for Aquaculture Technologies Canada (CATC) has received a licence that will allow it to conduct QC testing of regulated aquaculture vaccines.

The use of Halamid during vaccine administration effectively controls the risk of biosecurity breaches despite personnel and equipment moving from site to site.

​On April 17th, Hipra organised a theoretical training course in health and prevention, known as Hipra University, in Palma de Mallorca (Spain).

Sales of salmon vaccines in Norway ended at 13.1 million doses, up from 12.8 million doses in April 2017.

A vaccine to help protect sea bass against Vibriosis and Pasteurellosis was launched on the Greek market by Hipra this month.

Pharmaq’s new injectable vaccine to help fish farmers combat Nodavirus in European sea bass has received marketing authorisation in Spain, Italy, Croatia and Greece.

Developments in fish vaccines featured prominently at the latest - and last ever - gathering of the Veterinary Vaccinology Network.

On 1 November 2017, the Norwegian Medicines Agency granted Pharmaq authorisation to produce viral antigens at their new facility in Kløfta. The site has the capacity to produce several hundred million…

A new vaccine that's designed to protect catfish from columnaris disease is currently being developed by Auburn University.

Benchmark’s £17 million state-of-the-art vaccine antigen production facility in Braintree has now processed its first commercial-scale batch of antigen, which will be used in a number of new aquacultu…

MicroSynbiotiX, which is developing a microalgae-based delivery platform for oral administration of vaccines and functional feed additives for shrimp and fish, has secured seed funding.

Vaccination company prepares the ground for expansion.